X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (11) 11
male (9) 9
middle aged (8) 8
aged (7) 7
oncology (6) 6
prostatic neoplasms - drug therapy (5) 5
adult (4) 4
aged, 80 and over (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
docetaxel (4) 4
gonadotropin-releasing hormone - antagonists & inhibitors (4) 4
inflammation (4) 4
medical prognosis (4) 4
metastasis (4) 4
orchiectomy (4) 4
prostate cancer (4) 4
prostate-specific antigen - blood (4) 4
prostatic neoplasms - pathology (4) 4
prostatic neoplasms - surgery (4) 4
survival (4) 4
survival analysis (4) 4
zoledronic acid (4) 4
abridged index medicus (3) 3
androgens (3) 3
cancer (3) 3
clinical trials (3) 3
diphosphonates - administration & dosage (3) 3
disease-free survival (3) 3
genetics (3) 3
gonadotropin-releasing hormone - agonists (3) 3
imidazoles - administration & dosage (3) 3
medical research (3) 3
medicine, general & internal (3) 3
ophthalmology (3) 3
prostatic neoplasms - radiotherapy (3) 3
research (3) 3
treatment outcome (3) 3
analysis (2) 2
androgen antagonists - administration & dosage (2) 2
androgen antagonists - adverse effects (2) 2
androgen deprivation therapy (2) 2
androgen-deprivation therapy (2) 2
animals (2) 2
antineoplastic agents - therapeutic use (2) 2
article (2) 2
cancer therapies (2) 2
cause of death (2) 2
celecoxib - administration & dosage (2) 2
clinical-trials (2) 2
colorectal-cancer (2) 2
cyclooxygenase-2 inhibitors (2) 2
cytokines (2) 2
cytokines - genetics (2) 2
cytokines - metabolism (2) 2
dry eye disease (2) 2
dry eye syndromes - genetics (2) 2
early termination of clinical trials (2) 2
enzyme-linked immunosorbent assay (2) 2
epithelial cells - drug effects (2) 2
epithelial cells - metabolism (2) 2
epithelium, corneal - drug effects (2) 2
epithelium, corneal - metabolism (2) 2
female (2) 2
follow-up studies (2) 2
gene expression (2) 2
gene expression regulation - physiology (2) 2
genome-wide association (2) 2
genomics (2) 2
lymphatic metastasis (2) 2
men (2) 2
messenger-rna (2) 2
metastases (2) 2
mitoxantrone (2) 2
multiarm (2) 2
multistage (2) 2
neoplasm metastasis (2) 2
nonsteroidal anti-inflammatory drugs (2) 2
oncology, experimental (2) 2
open-label (2) 2
prednisone (2) 2
proportional hazards models (2) 2
prostate (2) 2
prostate-specific antigen (2) 2
prostatic neoplasms - mortality (2) 2
radiation therapy (2) 2
radiation-therapy (2) 2
radiotherapy (2) 2
radiotherapy - adverse effects (2) 2
randomized controlled-trial (2) 2
rna, messenger - metabolism (2) 2
sex determination (2) 2
stampede trial (2) 2
survival rate (2) 2
time factors (2) 2
tumors (2) 2
usage (2) 2
1506 (1) 1
3122 cancers (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10024, pp. 1163 - 1177
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 5, pp. 549 - 558
Journal Article
The Lancet, ISSN 0140-6736, 12/2018, Volume 392, Issue 10162, pp. 2353 - 2366
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2018, Volume 29, Issue 5, pp. 1235 - 1248
Abstract Background Adding abiraterone acetate with prednisolone (AAP) or docetaxel with prednisolone (DocP) to standard-of-care (SOC) each improved survival... 
Head-to-head | Treatment | Randomised | Abiraterone | Prostate cancer | Docetaxel | treatment | prostate cancer | randomised | abiraterone | head-to-head | docetaxel | Original
Journal Article
Journal Article
Experimental Eye Research, ISSN 0014-4835, 02/2013, Volume 107, pp. 88 - 100
A role for transforming growth factor (TGF)-β in the pathogenesis of some ocular surface diseases has been proposed. We determined if secretion of TGF-β and... 
cytokine | TGF-β | chemokine | dry eye disease | ocular surface epithelium | inflammation | Chemokine | Inflammation | Ocular surface epithelium | Dry eye disease | Cytokine | SIGNALING PATHWAYS | HUMAN CORNEA | INTERLEUKIN (IL)-4 | ALLERGIC CONJUNCTIVITIS | IMMUNOHISTOCHEMICAL LOCALIZATION | VERNAL KERATOCONJUNCTIVITIS | TGF-beta | GROWTH-FACTOR-BETA | DRY EYE | TRANSFORMING GROWTH-FACTOR-BETA-1 | REGULATORY T-CELLS | OPHTHALMOLOGY | Receptors, Transforming Growth Factor beta - genetics | Epithelial Cells - metabolism | Transforming Growth Factor beta2 - metabolism | Epithelial Cells - drug effects | Humans | Middle Aged | Transforming Growth Factor beta1 - metabolism | Male | RNA, Messenger - metabolism | Epithelium, Corneal - drug effects | Female | Real-Time Polymerase Chain Reaction | Fluorescent Antibody Technique, Indirect | Protein-Serine-Threonine Kinases - metabolism | Secretory Leukocyte Peptidase Inhibitor - metabolism | Transforming Growth Factor beta1 - pharmacology | Conjunctiva - cytology | Cell Line | Cytokines - metabolism | Enzyme-Linked Immunosorbent Assay | Electrophoresis, Polyacrylamide Gel | Protein-Serine-Threonine Kinases - genetics | Smad2 Protein - metabolism | Gene Expression Regulation - physiology | Proteoglycans - metabolism | Dry Eye Syndromes - genetics | Blotting, Western | Transforming Growth Factor beta2 - pharmacology | Receptors, Transforming Growth Factor beta - metabolism | Epithelium, Corneal - metabolism | Proteoglycans - genetics
Journal Article
Journal of Medical Genetics, ISSN 0022-2593, 03/2012, Volume 49, Issue 3, pp. 158 - 163
Journal Article